STAT

OCTOBER 16, 2023

If you’ve been following the mystery of long Covid since it emerged in 2020, you’ll recall interferons and serotonin have been clues from the start as combatants in the body’s prolonged battles against the virus. Theories about why symptoms persist long after the acute infection has cleared often point to two suspects: viral reservoirs where SARS-CoV-2 lingers and inflammation sparked by the infection that doesn’t subside.

364

364

PharmaVoice

OCTOBER 16, 2023

Billionaire investors and a new crop of longevity biotechs are betting big money on a lifespan-altering tipping point.

307

307

STAT

OCTOBER 16, 2023

Hospitals are frustrated with a nationwide nursing shortage that’s only gotten worse since the pandemic. In 2022, the American Hospital Association quoted an estimate that half a million nurses would leave the field by the end of that year, bringing the total shortage to 1.1 million. At the same time, National Nurses United insists there isn’t a nurse shortage at all.

Hospitals 363

Hospitals 363

PharmaVoice

OCTOBER 16, 2023

Biopharma leaders pounding away at rare diseases so patients with few other options can have healthier lives.

277

277

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 16, 2023

WASHINGTON — The White House is about to feel what it’s like to go up against the world’s most powerful tobacco companies. On Friday, the Food and Drug Administration requested White House clearance on a policy that would ultimately ban menthol cigarettes. The tobacco industry has already spent the last few months doing everything it can to drum up opposition, from drafting letters for members of Congress to rallying freedom-focused smokers, according to a review of advertis

Documentation 307

Documentation 307

ALiEM - Pharm Pearls

OCTOBER 16, 2023

An otherwise healthy 34-year-old male presented to the Emergency Department with two weeks of anterior neck pain. Symptoms began with several days of pain in his mandibular molars, progressing to pain and swelling in the neck. In the last several days, the patient developed warmth and redness in the chest wall associated with subjective fever and chills.

Hospitals 150

Hospitals 150

PharmaVoice

OCTOBER 16, 2023

A few key meetings remain this year, like ESMO and ASH, while next year’s events are already being planned. Here’s a list of conferences to keep in mind.

130

130

STAT

OCTOBER 16, 2023

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed. Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software.

300

300

Pharma Times

OCTOBER 16, 2023

The research aims to make MRIs more available to men and improve treatment decisions - News - PharmaTimes

148

148

STAT

OCTOBER 16, 2023

People with obesity often go underrepresented in drug development trials, a critical gap that researchers say leaves drugmakers and doctors unsure of efficacy or risks in that patient population. “Patients and providers are not aware of how some drugs may act differently in people with obesity,” said Christina Chow, the head of research at Emerald Lake Safety, an institution that conducts independent research to make pharmaceuticals safer.

Drug Development 293

Drug Development 293

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

FDA Law Blog: Biosimilars

OCTOBER 16, 2023

By Gail H. Javitt & Steven J. Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products. The first article—“Is the Eye the Window to Alzheimer’s?

Documentation 119

Documentation 119

STAT

OCTOBER 16, 2023

In the latest tussle over the cost of medicines, Teva Pharmaceuticals has filed a lawsuit alleging that a new Colorado program aimed at making epinephrine auto-injectors more affordable violates its constitutional rights. The lawsuit was filed in response to a state law that was passed in August and requires health insurers that provide coverage for these injectors to cap out-of-pocket costs to $60 for a package of two injectors.

Packaging 283

Packaging Drug Pricing 283

Drug Patent Watch

OCTOBER 16, 2023

In a systematic review titled “Influencers of Generic Drug Utilization,” researchers aimed to shed light on the key factors influencing the use of generic prescription drugs in the United States.… The post Influencers of Generic Drug Utilization appeared first on DrugPatentWatch - Make Better Decisions.

111

111

STAT

OCTOBER 16, 2023

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown. The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise.

248

248

The Pharmacist

OCTOBER 16, 2023

Discussions have taken place over the inclusion of pharmacy technicians in the delivery of the NHS New Medicine Service, according to Hammaad Patel, national pharmacy integration lead at NHS England. Speaking at the Pharmacy Show at NEC Birmingham today, Mr Patel expressed the view that pharmacy technicians were ‘well placed’ in community pharmacies to provide […] The post Inclusion of pharmacy technicians in New Medicine Service considered appeared first on The Pharmacist.

Pharmacy Technician 102

Pharmacy Technician Community Pharmacies 102

STAT

OCTOBER 16, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was sufficiently relaxing and invigorating, because that oh-so-familiar routine of online calls and deadlines has returned. After all, the world — such as it is — continues to spin. And to nudge it in a much-needed better direction, we are quaffing cups of stimulation.

Immunity 219

Immunity Immunization Vaccines 219

BioPharma Dive

OCTOBER 16, 2023

A few key meetings remain this year, like ESMO and ASH, while next year’s events are already being planned. Here’s a list of conferences to keep in mind.

105

105

STAT

OCTOBER 16, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! Today, cell and gene therapy executives describe how they’re handling their sector’s contraction, we talk about how regulators are cracking down on clinical decision support software, and we look at some impressive BTK data in multiple sclerosis from Roche.

Drug Development 210

Drug Development 210

Express Pharma

OCTOBER 16, 2023

Granules India and the National Institute of Pharmaceutical Education and Research (NIPER) in Mohali Chandigarh, announced the signing of a Memorandum of Understanding (MoU), to establish Dr Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD). This initiative aims to bring sustainability and innovation at the core of pharma research and development.

101

101

Outsourcing Pharma

OCTOBER 16, 2023

In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.

119

119

Pharma Times

OCTOBER 16, 2023

SOTIO will gain access to Synaffix’s three ADC technologies - News - PharmaTimes

128

128

European Pharmaceutical Review

OCTOBER 16, 2023

Lonza is planning to build a commercial-scale aseptic current good manufacturing practice (cGMP) filling line at its site in Stein, Switzerland. The new filling line will facilitate the aseptic filling of highly-potent antibody drug conjugates (ADCs) and lyophilisation under containment. The added capabilities will increase Lonza’s capacity to support clinical and commercial supply of bioconjugates.

Compounding 96

Compounding 96

Express Pharma

OCTOBER 16, 2023

Philogen and Sun Pharmaceutical Industries announce positive results from the Phase III PIVOTAL trial in patients with locally advanced fully resectable melanoma (NCT02938299). The study compared neoadjuvant intratumoral Nidlegy (Daromun) followed by surgery (treatment arm) vs. surgery alone (control arm). Patients were allowed to receive approved adjuvant systemic therapies after surgery in both arms.

94

94

Pharmaceutical Technology

OCTOBER 16, 2023

Pfizer is launching a $3.5bn cost-saving programme and BioNTech expects 2023 revenues to decrease as demand for Covid treatments wanes.

102

102

Outsourcing Pharma

OCTOBER 16, 2023

Patients with severe Alzheimer's Disease (AD) showed no cognitive decline throughout a ten-month trial while being treated with Bryostatin-1.

105

105

Pharmaceutical Technology

OCTOBER 16, 2023

Pfizer’s Elrexfio and Astellas’ Veozah are among the seven drugs recommended for approval by the European regulatory committee.

98

98

World Pharma News

OCTOBER 16, 2023

The genome of the SARS-CoV-2 virus encodes 29 proteins, one of which is an ion channel called E. This channel, which transports protons and calcium ions, induces infected cells to launch an inflammatory response that damages tissues and contributes to the symptoms of COVID-19. MIT chemists have now discovered the structure of the “open” state of this channel, which allows ions to flow through.

83

83

Pharmaceutical Technology

OCTOBER 16, 2023

The US FDA has granted approval for Bristol Myers Squibb’s (BMS) Opdivo to treat stage IIB or IIC melanoma patients.

98

98

The Pharmacist

OCTOBER 16, 2023

Former pharmacy minister Steve Brine has no concerns around the implementation of the upcoming pharmacy common conditions service, despite pressures on the sector, he has told The Pharmacist at today’s Pharmacy Show. And in a keynote address to delegates, the Health and Social Care Committee chair promised to put pressure on ministers regarding the medicines […] The post Exclusive: ‘No concerns’ about Pharmacy First implementation, says Steve Brine appeared first on The Pharmacist.

78

78

pharmaphorum

OCTOBER 16, 2023

Patient Centricity to Integration: Enhancing Cancer Outcomes Mike.

117

117

The Guardian - Pharmaceutical Industry

OCTOBER 16, 2023

I moved to New York this year and am embroiled in a Kafkaesque ordeal trying to get my meds filled Back in 2019, I was diagnosed with ADHD at age 40, a process I described for the Guardian. The diagnosis came as a surprise to me, but not to anyone I knew: sure, I’d never been especially hyperactive (or even, y’know, active), but the chronic lateness, difficulty concentrating, lack of emotional self-regulation and decades-long struggle to locate my keys … these were all classic symptoms.

75

75

Outsourcing Pharma

OCTOBER 16, 2023

AI start-up, Leucine, claims ânot fit for purposeâ compliance protocol processes are hindering the ability to deliver life-saving drugs faster.

98

98

pharmaphorum

OCTOBER 16, 2023

The UK market: A land of new opportunities for medical device manufacturers Mike.

99

99

Drug Patent Watch

OCTOBER 16, 2023

Annual Drug Patent Expirations for LUPKYNIS Lupkynis is a drug marketed by Aurinia and is included in one NDA. It is available from one supplier. There are three patents protecting… The post New patent expiration for Aurinia drug LUPKYNIS appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

OCTOBER 16, 2023

Bayer adds QR code to pack to help blind patients Phil.

111

111